These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10949204)

  • 41. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension.
    Findlay JY; Plevak DJ; Krowka MJ; Sack EM; Porayko MK
    Liver Transpl Surg; 1999 Sep; 5(5):362-5. PubMed ID: 10477835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
    Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.
    de Jesus Perez VA; Rosenzweig E; Rubin LJ; Poch D; Bajwa A; Park M; Jain M; Bourge RC; Kudelko K; Spiekerkoetter E; Liu J; Hsi A; Zamanian RT
    Am J Cardiol; 2012 Nov; 110(10):1546-50. PubMed ID: 22853986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
    Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
    J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of acute inhalation of nitric oxide in patients with primary pulmonary hypertension using chronic use of continuous epoprostenol infusion.
    Saji K; Sakuma M; Suzuki J; Takahashi T; Demachi J; Nawata J; Kitamukai O; Onoue N; Sugimura K; Tada T; Fukui S; Kagaya Y; Watanabe J; Shirato K
    Circ J; 2005 Mar; 69(3):335-8. PubMed ID: 15731541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.
    Sandifer BL; Brigham KL; Lawrence EC; Mottola D; Cuppels C; Parker RE
    J Appl Physiol (1985); 2005 Dec; 99(6):2363-8. PubMed ID: 16141385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system.
    Bein T; Metz C; Keyl C; Sendtner E; Pfeifer M
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):583-6. PubMed ID: 8847877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
    Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
    Aguilar RV; Farber HW
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1846-50. PubMed ID: 11069824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostacyclin in portopulmonary hypertension.
    Sinzinger H
    Wien Klin Wochenschr; 2000 Dec; 112(23):1020-1. PubMed ID: 11190712
    [No Abstract]   [Full Text] [Related]  

  • 55. Epoprostenol-induced hypersplenism in portopulmonary hypertension.
    Touma W; Nayak RP; Hussain Z; Bacon BR; Kudva GC
    Am J Med Sci; 2012 Nov; 344(5):345-9. PubMed ID: 22227513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
    Awdish RL; Cajigas HR
    Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
    Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
    Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Portopulmonary hypertension: an update.
    Safdar Z; Bartolome S; Sussman N
    Liver Transpl; 2012 Aug; 18(8):881-91. PubMed ID: 22674534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    Hanson SFL; Terry MH; Moretta DT; Power GG; Wilson SM; Alam F; Ahsan F; Blood AB; Giri PC
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):472-480. PubMed ID: 29756460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure.
    Schroeder RA; Wood GL; Plotkin JS; Kuo PC
    Anesth Analg; 2000 Aug; 91(2):291-5. PubMed ID: 10910834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]